Novavax logo
Novavax NVAX
$ 7.97 0.0%

Annual report 2025
added 02-26-2026

report update icon

Novavax P/S Ratio 2011-2026 | NVAX

Annual P/S Ratio Novavax

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
1.64 1.58 0.452 0.367 5.41 28 9.04 24.6 19.2 22.6 37.3 57.5 48.8 10.6 11.8

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
57.5 0.367 18.6

P/S Ratio of other stocks in the Biotechnology industry

Issuer P/S Ratio Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
1.75 - 2.43 % $ 254 M germanyGermany
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
131 $ 3.6 1.34 % $ 8.66 B australiaAustralia
Aytu BioScience Aytu BioScience
AYTU
0.237 $ 2.66 - $ 16.7 M usaUSA
BioNTech SE BioNTech SE
BNTX
35.7 $ 91.28 - $ 27.2 B germanyGermany
I-Mab I-Mab
IMAB
94.1 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
5.53 - - $ 40.3 B usaUSA
Genfit SA Genfit SA
GNFT
1.96 K - 2.54 % $ 160 B franceFrance
Burford Capital Limited Burford Capital Limited
BUR
6.35 $ 4.48 - $ 736 M britainBritain
Cerus Corporation Cerus Corporation
CERS
2.12 $ 1.85 - $ 353 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
137 - -18.52 % $ 27.3 M britainBritain
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.39 K - -1.52 % $ 24.7 M usaUSA
Acorda Therapeutics Acorda Therapeutics
ACOR
0.142 - -24.86 % $ 820 K usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
5.36 $ 1.67 - $ 196 M usaUSA
Celldex Therapeutics Celldex Therapeutics
CLDX
1.32 K $ 31.37 - $ 2.08 B usaUSA
CollPlant Biotechnologies Ltd. CollPlant Biotechnologies Ltd.
CLGN
10.4 $ 0.44 - $ 5.04 M israelIsrael
Advaxis Advaxis
ADXS
144 - -9.65 % $ 45.9 M usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
76.4 - - $ 86.2 M usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
2.61 - - - russiaRussia
Catalyst Pharmaceuticals Catalyst Pharmaceuticals
CPRX
5.16 $ 24.98 - $ 3.05 B usaUSA
Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings
CRBP
2.86 $ 10.14 - $ 135 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
196 $ 1.58 - $ 106 M usaUSA
Curis Curis
CRIS
1 $ 0.53 - $ 6.98 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
534 $ 37.7 - $ 3.55 B usaUSA
CRISPR Therapeutics AG CRISPR Therapeutics AG
CRSP
1.25 K $ 49.15 - $ 4.42 B schweizSchweiz
Aeterna Zentaris Aeterna Zentaris
AEZS
7.87 - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
0.099 - -10.17 % $ 12.2 K usaUSA
CytomX Therapeutics CytomX Therapeutics
CTMX
12.2 $ 4.4 - $ 607 M usaUSA
Citius Pharmaceuticals Citius Pharmaceuticals
CTXR
1.21 K $ 0.86 - $ 5.79 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
489 - - $ 1.01 B usaUSA
Cue Biopharma Cue Biopharma
CUE
1.07 $ 0.18 - $ 17.1 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
65.5 - - $ 26.5 M usaUSA
DBV Technologies S.A. DBV Technologies S.A.
DBVT
500 $ 20.36 - $ 2.84 B franceFrance
AIkido Pharma AIkido Pharma
AIKI
0.935 - 1.93 % $ 17.4 M usaUSA
Denali Therapeutics Denali Therapeutics
DNLI
7.68 $ 19.38 - $ 3.19 B usaUSA
Dyadic International Dyadic International
DYAI
10.2 $ 0.87 -2.8 % $ 31.5 M usaUSA
CureVac N.V. CureVac N.V.
CVAC
281 - - $ 867 M germanyGermany
Entera Bio Ltd. Entera Bio Ltd.
ENTX
83.8 $ 1.19 - $ 55.5 M israelIsrael
Equillium Equillium
EQ
1.77 $ 2.01 - $ 115 M usaUSA
Alnylam Pharmaceuticals Alnylam Pharmaceuticals
ALNY
11 $ 330.34 - $ 43.3 B usaUSA
Alpine Immune Sciences Alpine Immune Sciences
ALPN
8.94 - - $ 2.17 B usaUSA
Fate Therapeutics Fate Therapeutics
FATE
28.1 $ 1.19 - $ 141 M usaUSA